Hemab Therapeutics Holdings, Inc. · NASDAQ:COAG

Avoro Capital Advisors LLC reported a 7.06% stake in Hemab Therapeutics Holdings, Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Aug 14, 2026

Avoro Capital Advisors LLC reported a 7.06% stake in Hemab Therapeutics Holdings, Inc., 3,298,236 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).

Stake
7.06%
Shares
3,298,236
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Avoro Capital Advisors LLC4.12%1,925,150
Avoro Ventures LLC2.94%1,373,086
Behzad Aghazadeh7.06%3,298,236

Source

View original at SEC

Related